AMP Capital Investors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-42,020
| Closed | -$3.25M | – | 306 |
|
|
2021
Q3 | $3.25M | Sell |
42,020
-5,177
| -11% | -$408K | 0.02% | 646 |
|
|
2021
Q2 | $3.94M | Hold |
47,197
| – | – | 0.02% | 657 |
|
|
2021
Q1 | $3.56M | Sell |
47,197
-476
| -1% | -$38.9K | 0.02% | 680 |
|
|
2020
Q4 | $4.14M | Sell |
47,673
-27,286
| -36% | -$2.16M | 0.02% | 629 |
|
|
2020
Q3 | $5.7M | Buy |
74,959
+29,448
| +65% | +$2.98M | 0.03% | 494 |
|
|
2020
Q2 | $5.56M | Buy |
45,511
+447
| +1% | +$44.4K | 0.04% | 467 |
|
|
2020
Q1 | $3.72M | Buy |
45,064
+79
| +0.2% | +$6.81K | 0.03% | 533 |
|
|
2019
Q4 | $3.81M | Hold |
44,985
| – | – | 0.02% | 630 |
|
|
2019
Q3 | $3.07M | Sell |
44,985
-1,300
| -3% | -$100K | 0.02% | 660 |
|
|
2019
Q2 | $3.89M | Hold |
46,285
| – | – | 0.02% | 594 |
|
|
2019
Q1 | $4.06M | Sell |
46,285
-1,175
| -2% | -$109K | 0.02% | 591 |
|
|
2018
Q4 | $3.97M | Sell |
47,460
-87
| -0.2% | -$8.28K | 0.03% | 550 |
|
|
2018
Q3 | $4.66M | Sell |
47,547
-59,591
| -56% | -$5.95M | 0.03% | 567 |
|
|
2018
Q2 | $10.1M | Sell |
107,138
-15,202
| -12% | -$1.33M | 0.06% | 366 |
|
|
2018
Q1 | $9.74M | Sell |
122,340
-3,905
| -3% | -$335K | 0.06% | 377 |
|
|
2017
Q4 | $11.3M | Sell |
126,245
-2,665
| -2% | -$232K | 0.06% | 341 |
|
|
2017
Q3 | $12M | Sell |
128,910
-1,247
| -1% | -$110K | 0.07% | 309 |
|
|
2017
Q2 | $11.7M | Sell |
130,157
-2,520
| -2% | -$229K | 0.07% | 302 |
|
|
2017
Q1 | $11.8M | Buy |
132,677
+3,143
| +2% | +$280K | 0.07% | 305 |
|
|
2016
Q4 | $10.8M | Buy |
129,534
+2,135
| +2% | +$184K | 0.07% | 331 |
|
|
2016
Q3 | $11.8M | Buy |
127,399
+8,678
| +7% | +$817K | 0.07% | 285 |
|
|
2016
Q2 | $9.3M | Sell |
118,721
-2,206
| -2% | -$188K | 0.06% | 324 |
|
|
2016
Q1 | $9.44M | Sell |
120,927
-48,187
| -28% | -$3.92M | 0.06% | 317 |
|
|
2015
Q4 | $17.9M | Buy |
169,114
+8,449
| +5% | +$882K | 0.12% | 188 |
|
|
2015
Q3 | $15.6M | Sell |
160,665
-1,234
| -0.8% | -$165K | 0.11% | 198 |
|
|
2015
Q2 | $21.4M | Buy |
161,899
+49,748
| +44% | +$6.16M | 0.14% | 183 |
|
|
2015
Q1 | $14.5M | Buy |
112,151
+25,736
| +30% | +$2.73M | 0.09% | 259 |
|
|
2014
Q4 | $7.81M | Buy |
86,415
+59,932
| +226% | +$4.98M | 0.05% | 401 |
|
|
2014
Q3 | $1.93M | Buy |
26,483
+2,273
| +9% | +$149K | 0.01% | 746 |
|
|
2014
Q2 | $1.52M | Buy |
24,210
+1,347
| +6% | +$81.4K | 0.01% | 811 |
|
|
2014
Q1 | $1.51M | Buy |
22,863
+947
| +4% | +$69.8K | 0.01% | 790 |
|
|
2013
Q4 | $1.52M | Sell |
21,916
-7,755
| -26% | -$527K | 0.01% | 788 |
|
|
2013
Q3 | $2.2M | Buy |
29,671
+2,340
| +9% | +$156K | 0.02% | 681 |
|
|
2013
Q2 | $1.55M | Buy |
+27,331
| New | +$1.7M | 0.01% | 774 |
|
Other funds holding BMRN
BBA
AMP Capital Investors's BMRN Position: Q4 2021 in Review
AMP Capital Investors sold out of BioMarin Pharmaceuticals (BMRN) in Q4 2021, closing a stake of 42,020 shares — an estimated $3.25M sold.
AMP Capital Investors first reported a position in BMRN in Q2 2013 and held it in 34 quarters. The position peaked at $21.4M in Q2 2015. 557 funds tracked by Wall St. Rank hold BMRN as of Q4 2021.
- AMP Capital Investors reported no remaining BioMarin Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
- AMP Capital Investors sold 42,020 BioMarin Pharmaceuticals shares in Q4 2021, an estimated $3.25M.
- AMP Capital Investors first reported a position in BioMarin Pharmaceuticals in Q2 2013 and held it in 34 quarters.
- AMP Capital Investors's BioMarin Pharmaceuticals position peaked at $21.4M in Q2 2015.
- 557 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q4 2021.
Based on AMP Capital Investors's 13F filing for Q4 2021, filed 14 Feb 2022.